Recent advances in CD8+ regulatory T cell research (Review)

被引:93
作者
Yu, Yating [1 ]
Ma, Xinbo [1 ]
Gong, Rufei [1 ]
Zhu, Jianmeng [2 ]
Wei, Lihua [1 ]
Yao, Jinguang [1 ]
机构
[1] Guangxi Univ Sci & Technol, Dept Med Sch, 257 Liushi Rd, Liuzhou 545005, Guangxi, Peoples R China
[2] Dept Chunan First Peoples Hosp, Hangzhou 310000, Zhejiang, Peoples R China
关键词
CD8(+) regulatory T cells; immune regulation; Qa-1; CD8 alpha alpha(+); autoimmune disease; DENDRITIC CELLS; MULTIPLE-SCLEROSIS; FUNCTIONAL-CHARACTERIZATION; IMMUNE-RESPONSES; IN-VITRO; CD8(+)CD28(-); SUPPRESSOR; CD4(+); CANCER; QA-1;
D O I
10.3892/ol.2018.8378
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Various subgroups of CD8(+) T lymphocytes do not only demonstrate cytotoxic effects, but also serve important regulatory roles in the body's immune response. In particular, CD8(+) regulatory T cells (CD8(+) Tregs), which possess important immunosuppressive functions, are able to effectively block the overreacting immune response and maintain the body's immune homeostasis. In recent years, studies have identified a small set of special CD8(+) Tregs that can recognize major histocompatibility complex class Ib molecules, more specifically Qa-1 in mice and HLA-E in humans, and target the self-reactive CD4(+)T ce lls. These findings have generated broad implications in the scientific community and attracted general interest to CD8(+) Tregs. The present study reviews the recent research progress on CD8(+) Tregs, including their origin, functional classification, molecular markers and underlying mechanisms of action.
引用
收藏
页码:8187 / 8194
页数:8
相关论文
共 123 条
[1]   Limiting inflammation-the negative regulation of NF-κB and the NLRP3 inflammasome [J].
Afonina, Inna S. ;
Zhong, Zhenyu ;
Karin, Michael ;
Beyaert, Rudi .
NATURE IMMUNOLOGY, 2017, 18 (08) :861-869
[2]   PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine [J].
Ahmad, Shamaila Munir ;
Martinenaite, Evelina ;
Hansen, Morten ;
Junker, Niels ;
Borch, Troels Holz ;
Met, Ozcan ;
Donia, Marco ;
Svanea, Inge Marie ;
Andersen, Mads Hald .
ONCOIMMUNOLOGY, 2016, 5 (08)
[3]   Role of thymic B cells in the development of thymus-derived regulatory T cell in vitro [J].
Ali, Haider H. Mohammed ;
Drela, Nadzieja .
IMMUNOLOGY LETTERS, 2017, 185 :56-63
[4]   The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets [J].
Allard, Bertrand ;
Longhi, Maria Serena ;
Robson, Simon C. ;
Stagg, John .
IMMUNOLOGICAL REVIEWS, 2017, 276 (01) :121-144
[5]   Cardiovascular Involvement in Autoimmune Diseases [J].
Amaya-Amaya, Jenny ;
Montoya-Sanchez, Laura ;
Rojas-Villarraga, Adriana .
BIOMED RESEARCH INTERNATIONAL, 2014, 2014
[6]   Immune Regulation by Self-Recognition: Novel Possibilities for Anticancer Immunotherapy [J].
Andersen, Mads Hald .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (09)
[7]   Indoleamine 2,3-dioxygenase vaccination [J].
Andersen, Mads Hald ;
Svane, Inge Marie .
ONCOIMMUNOLOGY, 2015, 4 (01) :983770
[8]   CD8+CD28- T cells:: Certainties and uncertainties of a prevalent human T-cell subset [J].
Arosa, FA .
IMMUNOLOGY AND CELL BIOLOGY, 2002, 80 (01) :1-13
[9]  
Assadiasl S, 2014, IRAN J IMMUNOL, V11, P139, DOI IJIv11i3A1
[10]   CD8+ Foxp3+ Regulatory T Cells Are Induced during Graft-versus-Host Disease and Mitigate Disease Severity [J].
Beres, Amy J. ;
Haribhai, Dipica ;
Chadwick, Alexandra C. ;
Gonyo, Patrick J. ;
Williams, Calvin B. ;
Drobyski, William R. .
JOURNAL OF IMMUNOLOGY, 2012, 189 (01) :464-474